%0 Journal Article
%T A Review of Selective Laser Trabeculoplasty: "The Hype Is Real".
%A Sarenac T
%A Bečić Turkanović A
%A Ferme P
%A Gračner T
%J J Clin Med
%V 11
%N 13
%D Jul 2022 4
%M 35807163
%F 4.964
%R 10.3390/jcm11133879
%X Presently, there is no efficacious treatment for glaucomatous optic neuropathy; the current treatment is focused on lowering intraocular pressure (IOP). Studies have demonstrated the safety and efficacy of selective laser trabeculoplasty (SLT) in reducing the IOP in eyes with open-angle (OAG) glaucoma or ocular hypertension (OH). Moreover, the European Glaucoma Society has instated SLT as the first-line or adjunctive treatment in OAG or OH, reiterating its clinical significance. In this review, we outline the old and the new roles of SLT, with an emphasis on clinical practice, and look further into its renewed appeal and future developments.